Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Candel Therapeutics (CADL) Return on Assets (2021 - 2025)

Candel Therapeutics' Return on Assets history spans 3 years, with the latest figure at 0.01% for Q4 2023.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.01% in Q4 2023 year-over-year; TTM through Dec 2023 was 0.01%, a 0.0% change, with the full-year FY2023 number at 0.01%, changed 0.0% from a year prior.
  • Return on Assets hit 0.01% in Q4 2023 for Candel Therapeutics, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Assets for CADL hit a ceiling of 0.0% in Q4 2021 and a floor of 0.01% in Q4 2023.
  • Historically, Return on Assets has averaged 0.0% across 3 years, with a median of 0.0% in 2022.
  • The widest YoY moves for Return on Assets: up 0bps in 2022, down 0bps in 2022.
  • Tracing CADL's Return on Assets over 3 years: stood at 0.0% in 2021, then tumbled by -55bps to 0.0% in 2022, then tumbled by -97bps to 0.01% in 2023.
  • Business Quant data shows Return on Assets for CADL at 0.01% in Q4 2023, 0.01% in Q3 2023, and 0.01% in Q2 2023.